FDA Approves Updates To Lilly’s Humalog® (insulin Lispro Injection [rDNA Origin]) Label | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
Links shared publicly online about this topic.
- 231total visits
FDA Approves Updates To Lilly’s Humalog® (insulin Lispro Injection [rDNA Origin]) Label | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
View full resource at keyvive.com
Tags: Diabetes, Diabetes Type 1 Medication, Diabetes Type 2 Medication, Diabetes Medication, Insulin, Type 2 Diabetes, FDA, Humalog
Most Recently Shared on June 9, 2011 at 2:34 pm By:
FDA Approves Updates To Lilly’s Humalog® (insulin Lispro Injection [rDNA Origin]) Label: Eli… http://goo.gl/fb/HdrQt
Updated: FDA committee recommends Truvada’s approval as PrEP | Science Speaks: HIV & TB News
sciencespeaksblog.org — “Updated: FDA committee recommends Truvada’s approval as PrEP | Science Speaks: HIV & TB News” View full resource at sciencespeaksblog.org
Most Recently Shared on May 11, 2012 at 12:41 pm By:
FDA committee recommends Truvada’s approval as PrEP http://t.co/ZWClu3Zs
Latuda Dosing Range Updated - MPR
empr.com — “Sunovion announced that the FDA has approved an expanded dose range for Latuda (lurasidone) tablets in the treatment of adult patients with schizophrenia.” View full resource at empr.com
Most Recently Shared on May 7, 2012 at 6:52 pm By:
Latuda Dosing Range Updated #sunovion #antipsychotic #schizophrenia http://t.co/Bkpd52pO
Eli Lilly's Amyvid helps spot plaques linked to Alzheimer's – USATODAY.com
usat.ly — “The FDA's recent approval of a diagnostic tool developed by Eli Lilly for Alzheimer's disease is an important first step for early detection” View full resource at usat.ly
Most Recently Shared on April 11, 2012 at 7:15 pm By:
Alzheimer's Assoc. Health Organization
Dr. Thies of the #Alzheimer's Assoc. interviewed in @usatoday article about new Eli Lilly detection drug http://t.co/fV5kTOeN via @USATODAY
FDA Approves Alzheimer's Test Developed by Eli Lilly - WSJ.com
online.wsj.com — “The FDA approved an Eli Lilly test that can help detect Alzheimer's—a potential boon to treatment and developing drugs against the disease.” View full resource at online.wsj.com
Most Recently Shared on April 8, 2012 at 11:34 pm By:
Tom Heston, MD Doctor, Family Medicine Doctor, and Physician
Alzheimer Diagnosis Possible With Scan - Wall Street Journal http://t.co/gle8vhJV #health
Lilly says FDA approves brain imaging agent - Yahoo! News
news.yahoo.com — “From Yahoo! News: Eli Lilly and Co. said late Friday that the Food and Drug Administration approved Amyvid, a diagnostic imaging agent that is intended to help diagnose Alzheimer's disease.” View full resource at news.yahoo.com
Most Recently Shared on April 7, 2012 at 11:39 pm By:
Lilly says FDA approves brain imaging agent: Eli Lilly and Co. said late Friday that the Food and Drug Administr... http://t.co/KiJpJNHt
Affymax, Takeda Win Approval of Anemia Drug to Challenge Amgen | Xconomy
xconomy.com — “Affymax completed its surprising comeback today, as it won FDA clearance for its first marketed drug, a product for anemia that will be the first to rival a” View full resource at xconomy.com
Most Recently Shared on March 27, 2012 at 4:58 pm By:
Luke Timmerman Health Communicator
Update to Affymax FDA approval story, with comments from CEO John Orwin. Conf call coming later today. http://t.co/bG1ow9T0
House lawmakers propose FAST Act to speed approvals - Related Stories - AAP SmartBrief
smartbrief.com — “Reps. Cliff Stearns, R-Fla., and Edolphus Towns, D-N.Y., introduced a bill that would speed up commercialization of drugs for serious diseases. The Faster Access to Specialized Treatments Act would update and systematize the FDA's accelerated-approval program. ” View full resource at smartbrief.com
Most Recently Shared on March 13, 2012 at 11:26 pm By:
Clara Song Pediatrician, Physician, and Doctor
House lawmakers propose FAST Act to speed approvals http://t.co/zJVkXViW
UPDATE 1-FDA OKs AstraZeneca's influenza vaccine | Reuters
reuters.com — “Feb 29 (Reuters) - U.S. health regulators approvedAstraZeneca's vaccine to prevent seasonal influenza inpeople aged 2-49 years.The U.S. Food and Drug Administration said the vaccineFluMist Quadrivalent,” View full resource at reuters.com
Most Recently Shared on March 1, 2012 at 12:59 pm By:
RT @shelleypetersen: #FDA OKs AstraZeneca's quadrivalent FluMist vaccine http://t.co/P1W9uaIb #healthinnovations #pharma #nhs $AZN
Biogen Idec races to FDA and EMA with a blockbuster app for BG-12 - FierceBiotech
fiercebiotech.com — “Biogen Idec has filed an NDA on BG-12, taking another step forward in its blockbuster quest to gain an approval on its best near-term hope for a game-changing new treatment. Biogen ($BIIB) racked up Read more...” View full resource at fiercebiotech.com
Most Recently Shared on February 28, 2012 at 2:20 pm By:
Biogen Idec races to FDA and EMA with a blockbuster app for MS pill BG-12 http://t.co/xuhO69mT $BIIB #biotech $NVS
UPDATE 1-Pfizer says its drug is best hope for Alzheimer's - Yahoo! Finance UK
uk.finance.yahoo.com — “Read 'UPDATE 1-Pfizer says its drug is best hope for Alzheimer's' on Yahoo! Finance UK. * Says prior trials suggest edge over Lilly Alzheimer's drug * Says Prevnar 13 pneumonia data expected by 2013 * Expects FDA panel to review arthritis drug (Adds quotes from research chief, details on ...” View full resource at uk.finance.yahoo.com
Most Recently Shared on February 14, 2012 at 7:37 pm By:
UPDATE 1-Pfizer says its drug is best hope for Alzheimer's: * Says prior trials suggest edge over Lilly Alzheime... http://t.co/I53zjiUn
UPDATE 2-Roche breast cancer drug gets FDA priority review | Reuters
reuters.com — “* FDA pertuzumab U.S. approval decision due by June 8* Drug is used with Herceptin in HER2-positive patients* Roche shares up 1.9 percentFeb 7 (Reuters) - U.S. health regulators granted apriority review” View full resource at reuters.com
Most Recently Shared on February 7, 2012 at 6:01 pm By:
RT @cancerviews: Roche breast cancer drug gets FDA priority review - Reuters http://t.co/ffKfSu2l
The JC Virus Antibody Test Goes Public - New Treatments - Multiple Sclerosis
healthcentral.com — “Biogen Idec was pleased to announce last week that the FDA has approved an update to the prescription labeling of their monthly IV monoclonal antibody medicatio...” View full resource at healthcentral.com
Most Recently Shared on February 3, 2012 at 9:46 pm By:
The JC Virus Antibody Test Goes Public: Biogen Idec was pleased to announce last week that th... http://t.co/9VKQqoaO via @healthcentral
Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes
news-medical.net — “Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved Jentadueto (linagliptin/metformin hydrochloride) tablets, a new tablet combining the dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, and metformin.” View full resource at news-medical.net
Most Recently Shared on January 31, 2012 at 12:29 pm By:
Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes: Boehringer Ingelheim P... http://t.co/QrEPkXXO
UPDATE 2-US FDA approves Amylin's diabetes drug - Yahoo! Finance UK
uk.finance.yahoo.com — “Read 'UPDATE 2-US FDA approves Amylin's diabetes drug' on Yahoo! Finance UK. * Bydureon given as once-weekly shot * FDA rejected Bydureon twice before * Amylin has to conduct post-approval study: FDA (Adds details on drug, Amylin, competitors) WASHINGTON, Jan 27 (Reuters) - Amylin ...” View full resource at uk.finance.yahoo.com
Most Recently Shared on January 27, 2012 at 11:26 pm By:
UPDATE 2-US FDA approves Amylin's diabetes drug: * Bydureon given as once-weekly shot * FDA rejected Bydureon tw... http://t.co/B5Iy48nw
National MS Society Blog: FDA updates Tysabri label to include testing for PML risk
blog.nationalmssociety.org — “Julie Stachowiak, PhD Writer, ms.about.com The US Food and Drug Administration just approv...” View full resource at blog.nationalmssociety.org
Most Recently Shared on January 24, 2012 at 9:40 pm By:
Julie Stachowiak blogs about what #FDA updates to Tysabri labels mean for people living with #MS. http://t.co/nzjftwDf
Advertisement
